Project Grant R21AI190679
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $495,374 Project Grant award from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) on August 25, 2025, with a completion date of July 31, 2030. This award funds fundamental research investigating the human papillomavirus (HPV) life cycle with particular emphasis on R-loop formation and resolution. The research examines how HPV proteins manipulate cellular DNA...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division, a Project Grant of $230,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, obligated on August 12, 2025, with a completion date of July 31, 2027, supports research investigating the mechanism of dynein-mediated early intracellular...
- Federal Grant Award Summary Tufts University School of Medicine received a $6.32 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025 through July 31, 2029. The grant supports investigator-initiated biomedical research examining how Human Papillomavirus (HPV) E7 proteins reprogram host cell signaling pathways to facilitate viral replication and cellular...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 3, 2025, with completion targeted for August 31, 2027. This award supports research to characterize HIV-1 viral reservoirs and identify the cellular sources and genetic diversity of persistent viral populations in...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $156,160 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2027. This two-year career development award supports structural biology research focused on characterizing the molecular basis of human immunodeficiency virus-1 (HIV-1) accessory and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $811,033 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston, with an award date of September 4, 2025, and completion deadline of August 31, 2030. This prospective cohort study, entitled "Human Papillomavirus and Risk to Pregnancy," will examine the association between prenatal human...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $627,462 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 7, 2025, with a completion date of July 31, 2030. The research focuses on understanding T cell exhaustion in response to chronic viral infection through advanced immunological investigation. The project employs paired single-cell...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $440,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 5, 2026, with a completion date of January 31, 2028. The research, performed at Northwestern's Chicago, Illinois facility, investigates neutrophil priming as a novel method for training macrophage functional memory...
- Federal Grant Award Summary Northwestern University received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 9, 2026 through September 8, 2028. The award supports biomedical research investigating the metabolic regulation of regulatory T cells (Tregs) through fatty acid metabolism during viral pneumonia. The research focuses on understanding how Tregs...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $200,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026, through January 31, 2028. The research focuses on investigating the ubiquitin ligase TRIM39 as a host factor controlling Zika virus (ZIKV) infection. The project delivers basic biomedical research services...
Northwestern University's Sponsored Research Division received a $240,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 6, 2026, with a completion date of January 31, 2028. The research project, conducted in Chicago, Illinois, investigates human papillomavirus (HPV)-induced R-loops and their role in regulating innate immune gene expression. The study focuses on understanding how aberrant R-loops—trimeric nucleic acid structures formed during viral replication—activate DNA damage repair pathways (ATM and ATR) necessary for productive viral replication and how maintaining elevated R-loop levels suppresses innate immune regulatory genes. The project delivers basic biomedical research examining the molecular mechanisms underlying HPV pathogenesis, specifically exploring the relationship between R-loop formation, viral genome amplification in differentiated cells, episomal maintenance in undifferentiated cells, and immune evasion. The research addresses how viral proteins manipulate cellular DNA damage repair pathways and transcriptional regulation to facilitate productive infection. This investigator-initiated research contributes to scientific knowledge of infectious disease mechanisms and viral-host cell interactions, advancing understanding that may inform future therapeutic and preventive strategies for HPV-related diseases.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $240.0k | 2/6/26 |